[Biochemical markers of myocardial ischemia and necrosis].
The biochemical markers of myocardial ischaemia have to be interpreted according to their kinetics; their interests depend on the clinical presentation. They are helpful to orient to a myocardial ischaemia in front of undefined chest pain, to stratify the outcome of acute coronary syndrome without ST segment elevation, to evaluate the amount of myocardial damage following infarction, to detect the failure of thrombolysis therapy and probably to stratify the post percutaneous coronary intervention outcome.
Brasselet
C
C
Département de cardiologie, CHU Robert-Debré, avenue du Général-Koenig, 51092 Reims.
Tassan-Mangina
S
S
Durand
E
E
Perotin
S
S
Garnotel
R
R
Metz
D
D
Desnos
M
M
Elaerts
J
J
Lafont
A
A
D001145:Arrhythmias, Cardiac; D015415:Biomarkers / Q000032:analysis*; D002637:Chest Pain; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D007700:Kinetics; D017202:Myocardial Ischemia / Q000175:diagnosis* / Q000473:pathology; D009206:Myocardium / Q000473:pathology*; D009336:Necrosis; D012307:Risk Factors
D015415:Biomarkers; D005343:Fibrinolytic Agents